Viatris Inc. Share Price

Viatris Inc. Share Price

NASDAQ: VTRS | Large Cap
$19.04
-$0.18 (-0.91%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Viatris Inc. Stock Performance

Open
$19.32
Prev. Close
$19.21
Circuit Range
N/A
Day Range
$19.00 - $19.50
Year Range
$9.92 - $19.50
Volume
6,99,087
Average Traded
$19.10

Viatris Inc. Share Price Today

As of 31 October 2026, Viatris Inc.'s share price is $19.04. The stock opened at $19.32, compared to its previous close of $19.21. During today's trading session, Viatris Inc.'s share price traded between $19.00 and $19.50, with an average price of $19.25. Over the past 52 weeks, the stock has recorded a high of $19.50 and a low of $9.92. In terms of performance, Viatris Inc.'s share price has risen by 27.44% over the last six months and is up 83.78% on a year-on-year basis.

Viatris Inc. Share Price Chart

Line chart of the Viatris Inc. price trend over the selected period. The price fell overall, ranging from 19.00 to 19.16, ending at 19.04.
$19.00$19.50
L
Show Current Price
H

Viatris Inc. Stock Fundamentals & Key Indicators

Market Cap
$22.31B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.36
Revenue (TTM)
$14.30B
Return On Equity (TTM)
-2.88%
Profit Margin
-24.55%
Debt to Equity
0.94
Quarterly Earnings Growth YoY
7.33%

Viatris Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$3759.90$3703.60$3517.00$3756.80
Net Profit-$128.20-$340.10$176.40-$118.80
Net Profit Margin-3.41%-9.18%5.02%-3.16%
Income ChangeN/A-165.29%151.87%-167.35%

Viatris Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$16.26$15.43$14.74$14.30
Net Profit$2.08$0.05-$0.63-$3.51
Net Profit Margin12.79%0.32%-4.27%-24.55%
Income ChangeN/A-97.60%-1360.00%-457.14%

About Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.

Viatris Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$17.62
$19.02
+7.10%
Sep 2026
$16.61
$17.75
+5.12%
Aug 2026
$17.73
$16.89
-3.82%
Jul 2026
$15.99
$17.56
+10.51%
Jun 2026
$16.00
$15.89
-2.28%
May 2026
$14.91
$16.26
+8.84%
Apr 2026
$13.62
$14.94
+10.58%
Mar 2026
$14.91
$13.51
-9.39%
Feb 2026
$13.04
$14.91
+13.90%
Jan 2026
$12.48
$13.09
+5.06%
Dec 2025
$10.64
$12.46
+16.67%
Nov 2025
$10.31
$10.68
+3.09%

VTRS Share Price FAQs